Impact of the administration of liposomal amphotericin B in patients with renal function impairment at initiation of treatment.
Alvarez-Lerma
F
F
Servicio de Medicina Intensiva, Hospital Universitari del Mar, Autonomous University of Barcelona, Barcelona, Spain. Falvarez@imas.imim.es
Mariscal
F
F
Quintana
E
E
Rialp
G
G
Diaz-Reganon
J
J
Pérez San José
M J
MJ
Alvarez-Sanchez
B
B
D000666:Amphotericin B / Q000009:adverse effects*; D000935:Antifungal Agents / Q000009:adverse effects*; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D007674:Kidney Diseases / Q000097:blood; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy; D012189:Retrospective Studies
D000935:Antifungal Agents; C068538:liposomal amphotericin B; D000666:Amphotericin B; D003404:Creatinine